PWMG
VRTX icon

Private Wealth Management Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Private Wealth Management Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$27.2K Buy
52
+12
+30% +$6.14K 0.01% 343
2026
Q2 		$19.9K Hold
40
– – ﹤0.01% 387
2026
Q1 		$17.9K Buy
40
+5
+14% +$2.33K ﹤0.01% 369
2025
Q4 		$15.9K Sell
35
-7
-17% -$3.02K ﹤0.01% 380
2025
Q3 		$16.4K Hold
42
– – ﹤0.01% 381
2025
Q2 		$18.7K Sell
42
-1
-2% -$461 0.01% 319
2025
Q1 		$20.8K Sell
43
-1
-2% -$466 0.01% 287
2024
Q4 		$17.7K Buy
44
+2
+5% +$927 0.01% 330
2024
Q3 		$19.5K Buy
42
+1
+2% +$480 0.01% 294
2024
Q2 		$19.2K Buy
41
+7
+21% +$3.04K 0.01% 283
2024
Q1 		$14.2K Hold
34
– – 0.01% 337
2023
Q4 		$13.8K Buy
+34
New +$12.6K 0.01% 334

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
AMF Tjänstepension
AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Private Wealth Management Group's VRTX Position: Q3 2026 in Review

Private Wealth Management Group increased its Vertex Pharmaceuticals (VRTX) stake by 30% in Q3 2026, buying an estimated $6.14K and bringing the position to 52 shares worth $27.2K. The position accounts for 0.01% of the portfolio, ranked #343.

Private Wealth Management Group first reported a position in VRTX in Q4 2023 and has held it in 12 quarters since. 870 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Private Wealth Management Group held 52 shares of Vertex Pharmaceuticals worth $27.2K as of Q3 2026.
  • Private Wealth Management Group bought 12 Vertex Pharmaceuticals shares in Q3 2026, an estimated $6.14K.
  • Vertex Pharmaceuticals made up 0.01% of Private Wealth Management Group's portfolio in Q3 2026, its #343 holding.
  • Private Wealth Management Group first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 12 quarters since.
  • 870 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Private Wealth Management Group's 13F filing for Q3 2026, filed 19 Oct 2026.